ArisGlobal Presented “The Evolving Role of CTMS in Risk Management” at DIA 2020 Annual Meeting
On June 16th, 2020, ArisGlobal participated in the 2020 DIA ...
ArisGlobal Is Going “All-In” on Amazon AWS. Here Is What It Means to Our Customers.
ArisGlobal, part of the more cautious and highly regulated life science go “all-in on AWS” by moving the entire cloud infrastructure to the AWS platform. This move benefits both ArisGlobal and to our customers.
ArisGlobal Newscast: Industry’s Only E2B R3 Compliant Safety Multi-Tenant Cloud Platform
LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant ...
ArisGlobal Hosts Webinar Focusing on Regulatory Affairs Transformation Drivers for SMP Organizations
On May 14, 2020, ArisGlobal hosted a webinar titled Regulatory ...
ArisGlobal Hosts Optimizing Adverse Event Reconciliation in Medical Affairs Webinar
Many life sciences companies are still utilizing a manual process for their medical affairs needs. ArisGlobal’s LifeSphere ® Medical Affairs platform can help automate this process. Learn more about Medical Affairs and automated processes with our webinar, Optimizing Adverse Event Reconciliation in Medical Affairs.
ArisGlobal Insights – Interview with Sandeep Mahagaonkar
This is the fourth in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety business units at ArisGlobal. Director of Product Management – Medical Affairs and Quality, Sandeep Mahagaonkar, spoke about what attracted him to ArisGlobal, the state of Medical Affairs, and the vision for 2020 and beyond.
ArisGlobal Insights – Interview with Sondra Pepe
This is the first in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety product domains at ArisGlobal. Senior Director of Clinical Product Management, Sondra Pepe, describes what attracted her to ArisGlobal and articulated the vision for Clinical product strategy.
ArisGlobal Hosts 2020 Safety Advisory Board Meeting, Bringing Together Industry Leaders to Align on the Future of Pharmacovigilance
On May 19th and 20th, pharmacovigilance leaders from across the ...
ArisGlobal Differentiates Automation Hype from Reality in Pharmacovigilance for the Life Sciences Industry
During our recent webinar, when polled 43% of the audience said automating PV processes was one of their top strategic priorities, while 13% have no automation plan in place. That and other interesting insights are shared in this first of a three-part blog series.
ArisGlobal Expert Shares How Regulatory Affairs Needs to Adapt to Transformation Change
The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound effect on regulatory affairs.
